3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Wilms Tumor
2
Prostatic Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Breast Neoplasms
2
Adenocarcinoma, Bronchiolo-Alveolar
2
Adenocarcinoma of Lung
2
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Lung Neoplasms
1
Head and Neck Neoplasms
1
Germinoma
1
Extensive Stage Small Cell Lung Carcinoma
1
Ependymoma
1
Diabetes Insipidus
1
Carcinoma, Intraductal, Noninfiltrating
1
Carcinoma, Ductal, Breast
1
Breast Carcinoma In Situ
1
Anatomic Stage II Breast Cancer AJCC v8
1
Interventions
Magnetic Resonance Spectroscopy
9
Specimen Handling
7
X-Rays
6
Phantoms, Imaging
6
Nuclear Medicine Department, Hospital
5
Temozolomide
4
Biopsy
4
Vincristine
3
Cyclophosphamide
3
Cisplatin
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
pembrolizumab
2
palbociclib
2
olaparib
2
lutetium Lu 177 dotatate
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
Radiotherapy
2
Radiation
2
Platinum
2
Lomustine
2
LY3023414
2
Diphtheria-Tetanus Vaccine
2
1,2-diaminocyclohexaneplatinum II citrate
2
sodium thiosulfate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Medulloblastoma
×
Radiotherapy, Conformal
×
90 days
×
Clear all
No trials found.